Concord Healthcare's (HKG:2453) controlling shareholder, Medstar (Shanghai) Enterprise Management, acquired an additional 45,600 H shares of the company for HK$311,904, a Wednesday Hong Kong bourse filing said.
The shares, which were purchased from the open market for HK$6.84 apiece, represent roughly 0.01% of the Chinese oncology healthcare service provider's total issued share capital.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。